scPharmaceuticals Inc (NASDAQ: SCPH) is -46.41% lower on its value in year-to-date trading and has touched a low of $3.24 and a high of $6.71 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SCPH stock was last observed hovering at around $3.91 in the last trading session, with the day’s loss setting it -0.55%.
Currently trading at $3.36, the stock is -19.99% and -25.17% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.15 million and changing -14.07% at the moment leaves the stock -28.90% off its SMA200. SCPH registered -33.99% loss for a year compared to 6-month loss of -30.36%. The firm has a 50-day simple moving average (SMA 50) of $4.5266 and a 200-day simple moving average (SMA200) of $4.7337.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -23.81% gain in the last 1 month and extending the period to 3 months gives it a -35.26%, and is -22.22% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.53% over the week and 5.43% over the month.
scPharmaceuticals Inc (SCPH) has around 136 employees, a market worth around $168.09M and $30.28M in sales. Profit margin for the company is -264.60%. Distance from 52-week low is 3.70% and -49.93% from its 52-week high. The company has generated returns on investments over the last 12 months (-96.55%).
The EPS is expected to shrink by -12.98% this year
111.0 institutions hold shares in scPharmaceuticals Inc (SCPH), with institutional investors hold 67.19% of the company’s shares. The shares outstanding are 35.97M, and float is at 35.31M with Short Float at 11.69%. Institutions hold 61.51% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 5.56 million shares valued at $24.18 million. The investor’s holdings represent 14.2727 of the SCPH Shares outstanding. As of 2024-06-30, the second largest holder is RUBRIC CAPITAL MANAGEMENT LP with 3.52 million shares valued at $15.33 million to account for 9.0496 of the shares outstanding. The other top investors are AIGH CAPITAL MANAGEMENT LLC which holds 3.5 million shares representing 8.9966 and valued at over $15.24 million, while KING LUTHER CAPITAL MANAGEMENT CORP holds 5.6612 of the shares totaling 2.21 million with a market value of $9.59 million.
scPharmaceuticals Inc (SCPH) Insider Activity
The most recent transaction is an insider purchase by ORBIMED ADVISORS LLC, the company’s 10% Owner. SEC filings show that ORBIMED ADVISORS LLC bought 500,000 shares of the company’s common stock on Aug 13 ’24 at a price of $4.00 per share for a total of $2.0 million. Following the purchase, the insider now owns 5.81 million shares.
